![Matthew Feinsod](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 14 145 $ am 31.07.2026
Matthew Feinsod was the founder of Imagen Biotech, Inc., founded in 2011, where the title held was Chief Medical Officer.
Current jobs include Director at World Eye Mission, Executive VP-Global Strategy & Development at Beacon Therapeutics (USA), Inc. since 2019, and Chief Medical Officer at Kalaris Therapeutics, Inc. starting in 2025.
Former jobs include Senior VP-Strategy & Product Development at Oldtech, Inc., Member-Institutional Review Board at The George Washington University Hospital, and Medical Officer at the US Food & Drug Administration.
Education includes a doctorate from George Washington University and an undergraduate degree from The Wharton School of the University of Pennsylvania.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,02 % | 01.04.2026 | 4.030 ( 0,02 % ) | 14 145 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01.08.2019 |
World Eye Mission
 World Eye Mission Medical/Nursing ServicesHealth Services Engages in providing eye care services | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
The George Washington University Hospital
 The George Washington University Hospital Hospital/Nursing ManagementHealth Services Operates hospitals and healthcare centers | Corporate Officer/Principal | - |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | - |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | - |
Imagen Biotech, Inc.
 Imagen Biotech, Inc. BiotechnologyHealth Technology Develops therapeutics for blinding diseases | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The George Washington University Hospital
The George Washington University Hospital Hospital/Nursing ManagementHealth Services Operates hospitals and healthcare centers | Health Services |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Imagen Biotech, Inc.
Imagen Biotech, Inc. BiotechnologyHealth Technology Develops therapeutics for blinding diseases | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
World Eye Mission
World Eye Mission Medical/Nursing ServicesHealth Services Engages in providing eye care services | Health Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
